Schonfeld Strategic Advisors LLC Iveric Bio, Inc. Transaction History

Schonfeld Strategic Advisors LLC

  • $14.6 Billion
  • Q2 2024

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$26.24 - $39.63 $8.2 Million - $12.4 Million
-312,430 Reduced 91.6%
28,645 $1.13 Million
Q1 2023

May 15, 2023
BUY
$18.67 - $24.56 $1.41 Million - $1.86 Million
75,541 Added 28.45%
341,075 $8.3 Million
Q4 2022

Feb 14, 2023
BUY
$17.24 - $23.95 $620,036 - $861,361
35,965 Added 15.67%
265,534 $5.69 Million
Q3 2022

Nov 14, 2022
BUY
$9.4 - $18.59 $2.16 Million - $4.27 Million
229,569 New
229,569 $4.12 Million
Q1 2022

May 16, 2022
SELL
$12.15 - $16.83 $1.24 Million - $1.72 Million
-102,457 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$13.83 - $18.78 $1.25 Million - $1.7 Million
-90,343 Reduced 46.86%
102,457 $1.71 Million
Q3 2021

Nov 16, 2021
BUY
$7.07 - $17.5 $1.36 Million - $3.37 Million
192,800 New
192,800 $3.13 Million
Q4 2020

Feb 16, 2021
SELL
$5.65 - $7.66 $294,930 - $399,852
-52,200 Closed
0 $0
Q3 2020

Nov 16, 2020
BUY
$4.01 - $6.29 $106,666 - $167,314
26,600 Added 103.91%
52,200 $0
Q2 2020

Aug 14, 2020
SELL
$3.06 - $6.6 $18,360 - $39,600
-6,000 Reduced 18.99%
25,600 $131,000
Q1 2020

May 15, 2020
SELL
$2.83 - $8.44 $227,249 - $677,732
-80,300 Reduced 71.76%
31,600 $109,000
Q4 2019

Feb 14, 2020
BUY
$0.93 - $8.58 $104,067 - $960,102
111,900 New
111,900 $960,000

Others Institutions Holding ISEE

# of Institutions
7
Shares Held
250K
Call Options Held
40K
Put Options Held
0
View Full List

About IVERIC bio, Inc.

ISEE Quotes by TradingView
  • Ticker ISEE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,078,000
  • Description
  • IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...
More about ISEE
Track This Portfolio

Track Schonfeld Strategic Advisors LLC Portfolio

Follow Schonfeld Strategic Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email